Townsend Richard Nolan
Lexeo Therapeutics, Inc. Common Stock · Chief Executive Officer
Townsend Richard Nolan is listed in filings as Chief Executive Officer at Lexeo Therapeutics, Inc. Common Stock. This profile follows SEC Form 4 activity through May 20, 2026, including sale activity. Recent filings connect the profile to Lexeo Therapeutics, Inc. Common Stock (LXEO). The current snapshot covers public activity from Sep 11, 2024 to May 20, 2026. Reported amounts are shown as $16.9K to $6.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.